PD-L1 expression in 522 selected sarcomas with subset analysis of recurrent or metastatic matched samples and association with tumour-infiltrating lymphocytes
A. C. Vargas, F. M. Maclean, L. Sioson, D. Tran, F. Bonar, A. Mahar, A. L. Cheah, P. Russell, P. G. Peter Grimison, L. R. Louise Richardson, A. J. Gill
This study evaluates PD-L1 expression in 522 sarcomas, finding variability across subtypes and demonstrating increased PD-L1 in some metastatic/recurrent samples, suggesting potential for immune checkpoint inhibitor therapy.
bioRxiv · Sep 4, 2019Cancer Biology